Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Qiagen (QGEN) Liabilities and Shareholders Equity (2016 - 2025)

Qiagen's Liabilities and Shareholders Equity history spans 11 years, with the latest figure at $6.1 billion for Q4 2021.

  • For Q4 2021, Liabilities and Shareholders Equity rose 3.96% year-over-year to $6.1 billion; the TTM value through Dec 2024 reached $6.1 billion, down 49.03%, while the annual FY2021 figure was $6.1 billion, 3.96% up from the prior year.
  • Liabilities and Shareholders Equity for Q4 2021 was $6.1 billion at Qiagen, up from $5.9 billion in the prior quarter.
  • Across five years, Liabilities and Shareholders Equity topped out at $6.1 billion in Q4 2021 and bottomed at $5.2 billion in Q4 2019.
  • The 4-year median for Liabilities and Shareholders Equity is $5.8 billion (2018), against an average of $5.8 billion.
  • The largest annual shift saw Liabilities and Shareholders Equity fell 8.92% in 2019 before it increased 12.93% in 2020.
  • A 4-year view of Liabilities and Shareholders Equity shows it stood at $5.7 billion in 2018, then decreased by 8.92% to $5.2 billion in 2019, then grew by 12.93% to $5.9 billion in 2020, then rose by 3.96% to $6.1 billion in 2021.
  • Per Business Quant, the three most recent readings for QGEN's Liabilities and Shareholders Equity are $6.1 billion (Q4 2021), $5.9 billion (Q4 2020), and $5.2 billion (Q4 2019).